SEC Form 4 · accession 0001209191-15-009950
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger S Siboni
Director
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 6:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Feb 3, 2015 | A | 7,759 | $0.00 | A | 15,170 | D | |
| Class A Common StockF3,F2 | Feb 4, 2015 | S | 3,706 | $38.7536 | D | 11,464 | D | |
| Class A Common StockF4,F2 | Feb 5, 2015 | S | 3,705 | $39.1151 | D | 7,759 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Award represents a total of 7,759 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting.
- F2Shares held following the reported transactions include 7,759 restricted stock units, which are subject to forfeiture until they vest.
- F3This transaction was executed in multiple trades at prices ranging from $38.36 to $38.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F4This transaction was executed in multiple trades at prices ranging from $38.92 to $39.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Remarks
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.